Liver-Directed Therapy for Primary and Metastatic Liver Tumors: Cancer Treatment and Research, cartea 109
Editat de Mark S. Talamonti, Sam G. Pappasen Limba Engleză Paperback – 15 ian 2013
Because of the unique and comprehensive examination of liver tumors, this work is an excellent resource for surgical, transplant and medical oncologists, surgeons, gastroenterologists, and radiologists.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1054.90 lei 6-8 săpt. | |
Springer Us – 15 ian 2013 | 1054.90 lei 6-8 săpt. | |
Hardback (1) | 1063.32 lei 6-8 săpt. | |
Springer Us – 30 noi 2001 | 1063.32 lei 6-8 săpt. |
Din seria Cancer Treatment and Research
- 14% Preț: 960.70 lei
- 14% Preț: 632.65 lei
- 5% Preț: 757.81 lei
- 5% Preț: 998.60 lei
- 5% Preț: 993.53 lei
- 5% Preț: 1002.30 lei
- 5% Preț: 882.70 lei
- 5% Preț: 691.82 lei
- 5% Preț: 885.33 lei
- 5% Preț: 472.91 lei
- 5% Preț: 651.84 lei
- 5% Preț: 491.35 lei
- 5% Preț: 693.92 lei
- 5% Preț: 356.46 lei
- 15% Preț: 673.63 lei
- 5% Preț: 2036.46 lei
- 5% Preț: 1360.44 lei
- 5% Preț: 1370.13 lei
- 5% Preț: 1064.76 lei
- 5% Preț: 1248.42 lei
- 5% Preț: 1061.43 lei
- 5% Preț: 1052.98 lei
- 5% Preț: 1359.94 lei
- 5% Preț: 692.87 lei
- 5% Preț: 680.04 lei
- 5% Preț: 703.44 lei
- 5% Preț: 1361.14 lei
- 5% Preț: 1066.68 lei
- 5% Preț: 1056.49 lei
- 5% Preț: 1050.84 lei
- 5% Preț: 1057.89 lei
- 5% Preț: 1064.42 lei
Preț: 1054.90 lei
Preț vechi: 1110.43 lei
-5% Nou
Puncte Express: 1582
Preț estimativ în valută:
201.89€ • 212.99$ • 168.25£
201.89€ • 212.99$ • 168.25£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781475733730
ISBN-10: 1475733739
Pagini: 336
Ilustrații: XII, 322 p.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.47 kg
Ediția:2001
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
ISBN-10: 1475733739
Pagini: 336
Ilustrații: XII, 322 p.
Dimensiuni: 155 x 235 x 18 mm
Greutate: 0.47 kg
Ediția:2001
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1. Clinical Features of Primary and Metastatic Hepatic Malignancies.- 2. Pathologic Features of Primary and Metastatic Hepatic Malignancies.- 3. Radiologic Imaging and Staging of Primary and Metastatic Liver Tumors.- 4. Results of Surgical Resection for Hepatocellular Carcinoma.- 5. Indications and Results of Liver Transplantation for Primary and Metastatic Liver Cancer.- 6. Chemoembolization and Interstitial Therapies for Hepatocellular Carcinoma.- 7. Diagnosis and Management of Intrahepatic and Extrahepatic Cholangiocarcinoma.- 8. Gallbladder Cancer.- 9. Malignant Biliary Obstruction: Endoscopic Approaches.- 10. Biology of Liver Metastases.- 11. Results of Surgical Resection for Metastatic Liver Tumors.- 12. Resection for Recurrent Colorectal Liver Metastases.- 13. Surgical Resection of Hepatic Tumors — Patient Selection and Technical Considerations.- 14. Radiofrequency Ablation for Primary and Metastatic Liver Tumors.- 15. Cryosurgery for Primary and Metastatic Liver Tumors.- 16. Hepatic Artery Infusional Chemotherapy for Colorectal Liver Metastases.- 16. Pediatric Liver Tumors.
Recenzii
`The management of primary and metastatic disease in the liver remains one of the most important topics in cancer care. This text addresses the critical clinical and scientific issues associated with hepatic malignancies. A multidisciplinary group of experts highlight the latest therapeutic and research advances in the field.'
Steven T. Rosen, MD, Series Editor
`I have found it to be a very useful reference.It will appeal to both surgeons and physicians involved in the care of these patients and I recommend it strongly to any unit with an interest in the management of these patients...'
Cancer Forum, 26:3 (2002)
Steven T. Rosen, MD, Series Editor
`I have found it to be a very useful reference.It will appeal to both surgeons and physicians involved in the care of these patients and I recommend it strongly to any unit with an interest in the management of these patients...'
Cancer Forum, 26:3 (2002)